Sean McLoughlin
Chief Operating Officer at HILLEVAX, INC.
Net worth: 15 025 $ as of 2024-04-29
Profile
Mr. Sean McLoughlin is a Chief Operating Officer at HilleVax, Inc. Mr. McLoughlin was previously employed as a Vice President Global-Commercial Lead by GlaxoSmithKline LLC.
He received his undergraduate degree from Queen’S University Belfast and an MBA from St. Joseph's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HILLEVAX, INC
0.00% | 2024-03-27 | 1,250 ( 0.00% ) | 15 025 $ | 2024-04-29 |
Sean McLoughlin active positions
| Companies | Position | Start |
|---|---|---|
| HILLEVAX, INC. | Chief Operating Officer | 2024-01-15 |
Former positions of Sean McLoughlin
| Companies | Position | End |
|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Training of Sean McLoughlin
| Queen’S University Belfast | Undergraduate Degree |
| St. Joseph's University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| HilleVax, Inc. | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Sean McLoughlin
